XML 40 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Certain Financial Statement Caption Information - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Accrued Liabilities, Current [Abstract]    
Accrued payroll and other employee benefits $ 1,991 $ 3,054
Clinical development 3,436 1,850
Biocon chemistry, manufacturing and controls services 363 719
Biocon clinical development related to ulcerative colitis study 272 415
Non-clinical research 441 228
Other accruals 400 431
Total accrued expenses $ 6,903 $ 6,697